Home
cover of episode What Happened to 23andMe? Why Harris’ Plan to Tax Unrealized Gains Makes No Sense, and Time Really is Money

What Happened to 23andMe? Why Harris’ Plan to Tax Unrealized Gains Makes No Sense, and Time Really is Money

2024/9/11
logo of podcast The Prof G Pod with Scott Galloway

The Prof G Pod with Scott Galloway

Chapters

23andMe, once a promising genetic testing company, has seen its valuation plummet. Its struggles stem from missed revenue expectations, overspending, and an overestimation of market demand. The company's venture into drug discovery proved to be a costly misstep, contributing to its financial woes.
  • 23andMe's valuation dropped from $4.5 billion to $200 million.
  • The company's main revenue stream, consumer DNA testing, generated only $220 million last year.
  • NASDAQ warned about potential delisting of 23andMe's stock.

Shownotes Transcript

Scott speaks about the business of 23andMe, specifically how it illustrates what happens when growth companies don’t meet their growth expectations. He then discusses Kamala Harris’ plan to tax unrealized gains and why he doesn’t support it. He wraps up with a conversation on ways he spends his money to increase his productivity. 

Music: https://www.davidcuttermusic.com / @dcuttermusic

Subscribe to** No Mercy / No Malice**)

Buy "The Algebra of Wealth,") out now.

Follow the podcast across socials @profgpod:

- ** **Instagram)

- ** **Threads)

- ** **X)

- ** **Reddit)

Learn more about your ad choices. Visit podcastchoices.com/adchoices)